Fetal Fibronectin: The Benefits of a High Negative Predictive Value in Management of Preterm Labor

The clinical diagnosis of preterm labor (PTL) has up to a 50% false-positive rate, often leading to unnecessary hospitalizations and interventions. What objective tools can clinicians use to accurately diagnose true PTL - and reduce the drain on resources and overexposure to treatments?

" >

The clinical diagnosis of preterm labor (PTL) has up to a 50% false-positive rate, often leading to unnecessary hospitalizations and interventions. What objective tools can clinicians use to accurately diagnose true PTL - and reduce the drain on resources and overexposure to treatments?

This supplement discusses considerations and strategies for assessing PTL that include:

  • The role of diagnostic testing for fetal fibronectin (fFN) in the work up of women with symptoms of PTL
  • The importance of combining fFN values with cervical length measurement
  • Evidence-based protocols for the evaluation of PTL
  • A summary of evidence verifying the cost savings associated with the evaluation protocol

Read the supplement now to learn more about the management of PTL.

Download Supplement

Related Content
© 2023 MJH Life Sciences

All rights reserved.